Alkermes (ALKS) Enterprise Value (2010 - 2026)
Alkermes (ALKS) posted Enterprise Value of $8.12 billion for Q2 2026, up 119.1% from $3.71 billion a year earlier and up 51.1% from the prior quarter.
Alkermes (ALKS) Enterprise Value (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Enterprise Value at Alkermes was $5.91 billion, up 408.8% year-over-year; for FY2025, it came in at $4.05 billion, up 3.4% from FY2024.
- Annual Enterprise Value has increased for five consecutive years, with a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
- In prior years, Alkermes' Enterprise Value was $3.91 billion in FY2024 (+1.4%), $3.86 billion in FY2023 (+4.7%), $3.69 billion in FY2022 (+14.1%) and $3.23 billion in FY2021 (+27.2%).
- The Q2 2026 figure stands as the highest quarterly Enterprise Value since Q1 2018.
- On a year-over-year basis, Enterprise Value has increased in each of the last seven quarters, with growth averaging 22.7% over the last eight quarters.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q2 2026, with growth of 119.1%; the weakest was Q3 2022, with a decline of 30.2%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $5.37 billion (Q1 2026), $4.05 billion (Q4 2025) and $3.84 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.12 Bn |
| Mar 31, 2026 | 5.37 Bn |
| Dec 31, 2025 | 4.05 Bn |
| Sep 30, 2025 | 3.84 Bn |
| Jun 30, 2025 | 3.71 Bn |
| Mar 31, 2025 | 4.56 Bn |
| Dec 31, 2024 | 3.91 Bn |
| Sep 30, 2024 | 3.62 Bn |
| Jun 30, 2024 | 3.12 Bn |
| Mar 31, 2024 | 3.83 Bn |
| Dec 31, 2023 | 3.86 Bn |
| Sep 30, 2023 | 3.78 Bn |
| Jun 30, 2023 | 4.38 Bn |
| Mar 31, 2023 | 4.08 Bn |
| Dec 31, 2022 | 3.69 Bn |
| Sep 30, 2022 | 3.09 Bn |
| Jun 30, 2022 | 4.31 Bn |
| Mar 31, 2022 | 3.77 Bn |
| Dec 31, 2021 | 3.23 Bn |
| Sep 30, 2021 | 4.43 Bn |
Alkermes Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALKS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();